UTI Healthcare Fund Regular Plan-Growth - Returns, Rating & Analysis | Ionic Wealth
UTI Healthcare Fund Regular Plan-Growth
Equity
Sectoral-Pharma
₹0.12% 1D
NAV on
AI Summary
Chart
Overview
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Summary
Ionic AI
Loading...
Fund Overview
Rating
4
Minimum Investment
₹5000
NAV (Net Asset Value)
₹N/A
AUM (Fund size)
₹1144 Cr
Created on
N/A
Fund Ranking
#2
/ 14 in Sectoral-Pharma
Risk Level
Very High
Very High
Returns
Trailing Return
Rolling Return
6 Month
5.4%
1 Year
9.9%
3 Year (CAGR)
25.5%
All Time (CAGR)
14.7%
Category Return
6 Month
4.9%
1 Year
10.6%
3 Year (CAGR)
23.0%
All Time (CAGR)
-
Asset Allocation
Equity
95.3%
Other
4.7%
Top 5 Holdings
Top 5 Sectors
Apollo Hospitals Enterprise
3.54%
Aurobindo Pharma
2.46%
Caplin Point Laboratories
2.17%
Cipla
1.72%
Dr. Reddy's Laboratories
3.35%
Fund Information
Expense Ratio
2.16%
Exit Load
Exit load of 1% if redeemed within 30 days.
Lock-In Period
No Lock-In
Managed By
Kamal Gada
May 2022 - Present
Risk & Return Ratio
Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance.
1.15
Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment.
16.64
Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance.
0.95
Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility.